Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America

Carregando...
Imagem de Miniatura
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Autores
CORREIA, Maria Isabel Toulson Davisson
PERMAN, Mario Ignacio
PRADELLI, Lorenzo
OMARALSALEH, Abdul Jabbar
Citação
JOURNAL OF MEDICAL ECONOMICS, v.21, n.11, p.1047-1056, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aim: Disease-related malnutrition (DRM) is a prevalent condition that significantly increases the risk of adverse outcomes in hospitalized patients, particularly those with critical illness. Limited data is available on the economic burden of DRM and the cost-benefit of nutrition therapy in high-risk populations in Latin America. The aims of the present study were to estimate the economic burden of DRM and evaluate the cost-benefit of supplemental parenteral nutrition (SPN) in critically ill patients who fail to receive adequate nutrient intake from enteral nutrition (EN) in Latin America. Methods: Country-specific cost and prevalence data from eight Latin American countries and clinical data from studies evaluating outcomes in patients with DRM were used to estimate the costs associated with DRM in public hospitals. A deterministic decision model based on clinical outcomes from a randomized controlled study and country-specific cost data were developed to examine the cost-benefit of administering SPN to critically ill adults who fail to reach >= 60% of the calculated energy target with EN. Results: The estimated annual economic burden of DRM in public hospitals in Latin America is $10.19 billion (range, $8.44 billion-$11.72 billion). Critically ill patients account for a disproportionate share of the costs, with a 6.5-fold higher average cost per patient compared with those in the ward ($5488.35 vs. $839.76). Model-derived estimates for clinical outcomes and resource utilization showed that administration of SPN to critically ill patients who fail to receive the targeted energy delivery with EN would result in an annual cost reduction of $10.2 million compared with continued administration of EN alone. Limitations: The cost calculation was limited to the average daily cost of stay and antibiotic use. The costs associated with other common complications of DRM, such as prolonged duration of mechanical ventilation or more frequent readmission, are unknown. Conclusions: DRM imposes a substantial economic burden on Latin American countries, with critically ill patients accounting for a disproportionate share of costs. Cost-benefit analysis suggests that both improved clinical outcomes and significant cost savings can be achieved through the adoption of SPN as a therapeutic strategy in critically ill patients who fail to receive adequate nutrient intake from EN.
Palavras-chave
Disease-related malnutrition, pharmacoeconomics, supplemental parenteral nutrition, enteral nutrition, intensive care, Latin America
Referências
  1. Alvarez-Hernandez J, 2012, NUTR HOSP, V27, P1049, DOI 10.3305/nh.2012.27.4.5986
  2. Arreguin Nava R, 2012, REV DIGITAL U, V13, P3
  3. AssociacAo de Medicina Intensiva Brasileira, 2016, CENS
  4. Benkovic V, 2014, CLIN NUTR, V33, P689, DOI 10.1016/j.clnu.2013.09.006
  5. Brito PA, 2013, NUTRITION, V29, P646, DOI 10.1016/j.nut.2012.11.008
  6. Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662
  7. Correia MITD, 2017, CLIN NUTR, V36, P958, DOI 10.1016/j.clnu.2016.06.025
  8. Correia MITD, 2003, NUTRITION, V19, P823, DOI 10.1016/S0899-9007(03)00168-0
  9. Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7
  10. Curtis LJ, 2017, CLIN NUTR, V36, P1391, DOI 10.1016/j.clnu.2016.09.009
  11. da Cruz PadrAo M, 2010, REV BRAS CLIN MED, V8, P125
  12. Dal-Paz K, 2010, BRAZ J INFECT DIS, V14, P356, DOI 10.1590/S1413-86702010000400008
  13. de Leon-Rosales SP, 2000, CRIT CARE MED, V28, P1316, DOI 10.1097/00003246-200005000-00010
  14. Dennis R. J., 2000, ACTA MED COLOMB, V25, P211
  15. Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124
  16. Duarte Molino P, 2012, REV ASOC MEX MED CRI, V26, P85
  17. Elia M, 2009, COMBATING MALNUTRITI
  18. Fontes D, 2014, CLIN NUTR, V33, P291, DOI 10.1016/j.clnu.2013.05.004
  19. Freijer K, 2013, CLIN NUTR, V32, P136, DOI 10.1016/j.clnu.2012.06.009
  20. Espinosa SG, 2014, NUTR HOSP, V30, P425, DOI 10.3305/nh.2014.30.2.7559
  21. Giraldo Giraldo N. A., 2007, Perspectivas en Nutricion Humana, V9, P37
  22. Goates S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161833
  23. Goldwasser RS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050005997, 10.1590/s1518-8787.2016050005997]
  24. Harvey SE, 2014, NEW ENGL J MED, V371, P1673, DOI 10.1056/NEJMoa1409860
  25. Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8
  26. IESS Hospital San Francisco de Quito., 2016, INF GEST
  27. Inotai A., 2012, e-SPEN Journal, V7, pe196
  28. Instituto Nacional de Estadistica y Censos, GOB NAC REP EC 2015
  29. Instituto Nacional de Estadistica y Censos Gobierno Nacional de la Republica del Ecuador, AN EST HOSP CAM EGR
  30. Leandro-Merhi VA, 2011, JPEN-PARENTER ENTER, V35, P241, DOI 10.1177/0148607110374477
  31. Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001
  32. Linthicum MT, 2015, ASIA-PAC J PUBLIC HE, V27, P407, DOI 10.1177/1010539514552702
  33. Lunardi AC, 2012, RESPIROLOGY, V17, P108, DOI 10.1111/j.1440-1843.2011.02049.x
  34. Marconi EH, 2015, EGRESOS ESTABLECIMIE
  35. Marconi EH, 2003, SPECIAL PUBLICATION, V4
  36. McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI 10.1177/0148607115621863
  37. Ministerio da Saude/SE/Datasus, 2012, SIST INF HOSP SUS SI
  38. Ministerio de Salud Departamento de Estadisticas e Informacion de Salud, 2014, EGR SEG ED CAUS EGR
  39. Ministerio de Salud Departamento de Estadisticas e Informacion de Salud, 2013, EGR SEG ED CAUS EGR
  40. Ministerio de Salud Oficina General de Estadistica e Informatica area de Investigacion y Analisis, 2013, COMP EST EGR HOSP 20
  41. Ministerio de Salud Programa Nacional de Vigilancia de Infecciones Hospitalarias de Argentina (VIHDA), 2015, EST NAC DIAGN I PREV
  42. Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007
  43. OECD, HOSP DISCH RAT, DOI [10. 1787/5880c955-en, DOI 10.1787/5880C955-EN]
  44. OECD, 2015, HLTH GLANC 2015 OECD, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]
  45. Ordonez AM, 2013, NUTR HOSP, V28, P1313, DOI 10.3305/nh.2013.28.4.6609
  46. Otaiza O'Ryan F, 2015, INFORME VIGILANCIA I
  47. Vallejo KP, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1805-z
  48. Pasquini TAS, 2012, BRAZ J MED BIOL RES, V45, P1301, DOI [10.1590/1414-431X20122586, 10.1590/S0100-879X2012001200028]
  49. Perman M, 2001, RNC REV NUTR CLIN, V10, P121
  50. Pradelli L, 2018, CLIN NUTR, V37, P573, DOI 10.1016/j.clnu.2017.01.009
  51. Quispe Pardo Z, 2015, ESTUDIO NACL PREVALE
  52. Rice N, 2012, PUBLIC HEALTH NUTR, V15, P1966, DOI 10.1017/S1368980011003624
  53. Rios de Tejera H, 2005, THESIS
  54. Rodriguez-Burbano Lady, 2016, Rev Salud Publica (Bogota), V18, P104, DOI 10.15446/rsap.v18n1.36905
  55. Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002
  56. Rowell DS, 2011, EUR J HEALTH ECON, V12, P353, DOI 10.1007/s10198-010-0245-3
  57. Salvatierra-Gonzalez MR, 2003, COST NOSOCOMIAL INFE
  58. Sanchez DE, 2008, FACTORES RELACIONADO
  59. SATI Q, 2015, INF GEN UCI ADULT
  60. Schmunis GA, 2008, REV PANAM INFECTOL, V10, pS70
  61. Secretaria de Salud, 2011, MED PREV INF NOS HOS
  62. Secretaria de Salud, 2015, MH 2015 MEJ HOSP SEC
  63. Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024
  64. Snider JT, 2014, JPEN-PARENTER ENTER, V38, p77S, DOI 10.1177/0148607114550000
  65. Uedelhoven KW, 2007, MANGELERNAEHRUNG DEU
  66. Volkow P, 2011, SALUD PUBLICA MEXICO, V53, P345, DOI [10.1590/S0036-36342011000400010, 10.1590/s0036-36342011000400010]
  67. Waitzberg DL, 2001, NUTRITION, V17, P573, DOI 10.1016/S0899-9007(01)00573-1
  68. Wyszynski DF, 2003, NUTRITION, V19, P115, DOI 10.1016/S0899-9007(02)00925-5